Determining the smallest worthwhile difference of beta-3 agonist treatment for overactive bladder: a benefit-harm trade-off study

World Journal of Urology 2026 Open access

Read full text
Authors: Kenji Omae, Yan Luo, Ethan Sahker, Aran Tajika, Yuki Kataoka, Noritoshi Sekido, Toshi A. Furukawa
DOI: 10.1007/s00345-026-06274-8
Cited by: 1
References: 30

Fields of Study & Subjects

Urinary Bladder and Prostate Research Bladder and Urothelial Cancer Treatments Frailty in Older Adults

Publication details

Journal / source
World Journal of Urology
Publisher
Springer Science and Business Media LLC
Volume
44
Issue
1
Pages
175–175
Publication date
16 February 2026
Language
EN